VolitionRx Limited (VNRX)

VolitionRx Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.8	0.78	0.31	0.09	0.01	0.02
Revenue Growth (YoY)	133.06%	153.04%	240.30%	570.25%	-21.43%	-
Gross Profit	0.8	0.78	0.31	0.09	0.01	0.02
Selling, General & Admin	16.85	17.21	16.75	15.4	6.73	5.7
Research & Development	19.28	19.55	15.33	13.02	14.53	10.36
Operating Expenses	36.12	36.76	32.09	28.42	21.26	16.06
Operating Income	-35.33	-35.99	-31.78	-28.33	-21.25	-16.04
Interest Expense / Income	0.25	0.22	0.17	0.16	0.13	0.13
Other Expense / Income	-0.67	-0.89	-1.68	-1.67	-1.03	-0.07
Pretax Income	-34.91	-35.32	-30.27	-26.81	-20.35	-16.1
Net Income	-34.91	-35.32	-30.27	-26.81	-20.35	-16.1
Shares Outstanding (Basic)	82	71	55	53	45	39
Shares Outstanding (Diluted)	82	71	55	53	45	39
Shares Change	36.19%	28.70%	5.12%	16.29%	15.57%	24.82%
EPS (Basic)	-0.46	-0.50	-0.55	-0.51	-0.45	-0.41
EPS (Diluted)	-0.46	-0.50	-0.55	-0.51	-0.45	-0.41
Free Cash Flow	-18.57	-19.15	-16.85	-21.83	-18.11	-13.25
Free Cash Flow Per Share	-0.23	-0.27	-0.30	-0.41	-0.40	-0.34
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-4432.36%	-4641.76%	-10372.36%	-31468.96%	-158176.25%	-93840.22%
Profit Margin	-4379.63%	-4555.53%	-9879.11%	-29782.49%	-151508.34%	-94168.55%
Free Cash Flow Margin	-2330.23%	-2469.59%	-5498.81%	-24243.33%	-134832.07%	-77507.73%
EBITDA	-33.26	-33.68	-28.91	-25.51	-19.18	-15.07
EBITDA Margin	-4172.82%	-4344.65%	-9434.24%	-28337.54%	-142789.72%	-88149.69%
Depreciation & Amortization	1.4	1.41	1.19	1.15	1.04	0.9
EBIT	-34.66	-35.1	-30.1	-26.66	-20.22	-15.97
EBIT Margin	-4348.57%	-4526.94%	-9822.61%	-29609.44%	-150542.07%	-93428.19%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).